Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Drug Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107746861A details a biocatalytic route for high-purity chiral alcohols. Discover cost-effective supply chain solutions for API intermediates.
Advanced patent CN101351438A details a safer, scalable route to Tamiflu intermediates using transketalization, eliminating toxic reagents and solid isolations for cost-effective manufacturing.
Novel decarboxylation route for FGFR inhibitor intermediate offers high yield and purity. Ideal for cost reduction in API manufacturing and scalable supply chains.
Patent CN106047950A details enzymatic reduction for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN112409431B reveals novel cytarabine structural analogs with superior oral bioavailability. Discover cost-effective manufacturing solutions for high-purity leukemia intermediates.
Advanced synthesis of 5-(4-methyl-1H-imidazol-1-yl)-3-trifluoromethyl-aniline via patent CN102174020B. Delivers superior purity, safety, and cost efficiency for kinase inhibitor supply chains.
Patent CN113773241A details a novel Pd/Al2O3 catalytic route for N-methyl indole, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN102180836B reveals a safer, cost-effective method for synthesizing kinase inhibitor intermediates, offering significant supply chain advantages.
Discover the cost-effective palladium-catalyzed manufacturing method for piperidine-3-ylcarbamate intermediates. Enhance supply chain reliability and reduce production costs for diabetes drug synthesis.
Novel L-alanine catalyzed route improves yield and purity for KRAS G12C inhibitor intermediates, offering cost-effective scale-up solutions.
Patent CN114773309A details a high-yield synthesis of Hepatitis C intermediates using Lewis acid catalysis, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN100537563C reveals a streamlined acid-catalyzed condensation for N-phenyl-2-pyrimidinamine derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Patent CN114702471A details a green air-oxidation method for caronic anhydride, replacing hazardous ozone processes to ensure reliable pharmaceutical intermediate supply.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN113072480A reveals a scalable chemical resolution route for chiral (-)-5-azaspiro[2.4]heptane-7-alcohol, offering superior purity and cost efficiency for API manufacturing.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN112724089B details a high-yield bromination process for 2-amino-3-bromo-6-chloropyrazine, offering significant cost reduction and scalable production for SHP2 inhibitor intermediates.
Patent CN108101857B details a high-yield route for 2-amino-3-bromo-6-chloropyrazine, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102558098A reveals a cost-effective one-pot synthesis for EGFR inhibitor intermediates, offering significant supply chain advantages for API manufacturers.